Journal of Pediatric Neurology 2011; 09(01): 059-061
DOI: 10.3233/JPN-2010-0445
Georg Thieme Verlag KG Stuttgart – New York

A novel mutation in a family with complicated X linked spastic paraplegia

Autor*innen

  • Sushil Beri

    a   Department of Pediatric Neurology, University Hospital of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester, UK
  • Jayaprakash A. Gosalakkal

    a   Department of Pediatric Neurology, University Hospital of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester, UK
  • Nahin Hussain

    a   Department of Pediatric Neurology, University Hospital of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester, UK
  • Srinivas Parepalli

    a   Department of Pediatric Neurology, University Hospital of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester, UK
  • Sujata Kanhere

    a   Department of Pediatric Neurology, University Hospital of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester, UK

Verantwortlicher Herausgeber dieser Rubrik:
Weitere Informationen

Publikationsverlauf

23. Juli 2009

26. Oktober 2009

Publikationsdatum:
30. Juli 2015 (online)

Abstract

Proteolipid protein 1 (PLP1) related disorders of central nervous system myelin formation; span a continuum to include a range of phenotypes from Pelizaeus-Merzbacher disease to X linked spastic paraplegia 2. Spastic paraplegia 2 is allelic to Pelizaeus-Merzbacher disease and typically caused by missense mutations in the second extracellular domain of PLP1. We report a family with two brothers, age 4 and 2 years respectively with developmental delay, speech problems and spastic quadriplegia. Their mother had mild symptoms since the age of 3 years with a diagnosis of ‘spastic diplegia’. Molecular genetics confirmed that the family had a premature stop codon at tyrosine 104 (p Tyr104X) a novel mutation in exon 3 of PLP1 gene. This mutation resulted in a truncated PLP1 protein. To the best of our knowledge, this is a novel mutation and has not been described before.